Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class ASSE: 688621

"Beijing Sun-Novo Pharmaceutical Research Co., Ltd."Announcement on Voluntary Disclosure of External Investment

Jul 29, 2026 · Issued by Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Voluntary Disclosure of External Investment

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A

"Beijing Sun-Novo Pharmaceutical Research Co., Ltd."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Jul 21
"Beijing Sun-Novo Pharmaceutical Research Co., Ltd."Indicative Announcement on the Transfer by Agreement of Certain Shares of the Company by the Controlling Shareholder and the Actual Controller, and the Resulting Change in Equity InterestsJul 17
"Beijing Sun-Novo Pharmaceutical Research Co., Ltd."Announcement of Voluntary Disclosure of Semi-annual Performance Forecast for 2026Jul 15
"Beijing Sun-Novo Pharmaceutical Research Co., Ltd."Special Report on the Use of Previously Raised FundsJul 4

All Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A news releases